Reports of lymphadenopathy were imbalanced. The frequency and severity of systemic adverse events was higher after dose 2 than dose 1. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. For each dose and age group, reactions were reported most frequently the day after vaccination. No serious adverse events were considered as possibly related to the vaccine. "She still cannot digest food. CDC and FDA will continue to monitor for adverse events, including myocarditis, after mRNA COVID-19 vaccination and share available data with ACIP to guide risk-benefit assessments for all COVID-19 vaccines. 1600 Clifton Road, N.E., Mailstop A27 * https://covid.cdc.gov/covid-data-tracker/#datatracker-home, https://vaers.hhs.gov/faq.htmlexternal icon, Each VAERS report might be assigned more than one MedDRA preferred term. Cookies used to make website functionality more relevant to you. She suffered a severe systemic adverse reaction to her second dose of the shot, however, and struggled through 11 ER visits and four hospital admissions in the year and a half that followed. bMild: hurts if gently touched; moderate: hurts if gently touched with crying; severe: causes limitation of limb movement; Grade 4: emergency room visit or hospitalization for severe tenderness at the injection site. Grade 3, or severe, local or systemic reactions within 7 days following either vaccination, were reported by 10.7% of vaccine recipients, and occurred more frequently in the vaccine than placebo groups (Table 3d). These surveillance activities were reviewed by CDC and conducted consistent with applicable federal law and CDC policy.. bMild: 1 to 2 times in 24 hours; moderate: >2 times in 24 hours; severe: requires intravenous hydration; Grade 4: emergency room visit or hospitalization for severe vomiting. Myocarditis was listed among 4.3% (397) of all VAERS reports. In the hours following the news, some conspiratorial Twitter users began to speculate that the cause of Presley's death at the age of 54 was a COVID-19 vaccine or booster shot. Thank you for taking the time to confirm your preferences. The Pfizer and Moderna vaccines are absolutely safe for children over 12 years. Department of Health and Human Services. No serious concerns impacted the certainty of the estimate of reactogenicity. January 12, 2023 3:04pm. Mother Stephanie De Garay joins 'Tucker Carlson Tonight' to discuss how her 12-year-old daughter volunteered for the Pfizer vaccine trial and is now in a wheelchair. One grade 4 fever (>40.0C) was reported in the vaccine group. Abbreviations: CI= confidence interval;RR =relative risk; COVID-19 = coronavirus disease 2019; RCT = randomized controlled trial. A standard continuity correction of 0.5 was used when zero events were observed in one or both arms [6]. It contains a lower amount of mRNA than the Pfizer-BioNTech COVID-19 vaccine used for people age 12 and older. Marshall M, Ferguson ID, Lewis P, et al. Pfizer and Moderna mRNA vaccines are approved for youth 12 years of age and older. We have no reason to expect that children would tolerate the vaccine less favorably than adults would. Cookies used to make website functionality more relevant to you. (Table 6). CDC and FDA continue to monitor vaccine safety and provide data to ACIP to guide COVID-19 vaccine recommendations. The remaining SAEs were considered by FDA to be unrelated to the study vaccine. COVID-19 vaccines side effects are generally mild to moderate in children. Abbreviations: RT-PCR = real-time polymerase chain reaction; CI = confidence interval; RR = relative risk. No other systemic grade 4 reactions were reported. Weekly / August 6, 2021 / 70(31);1053-1058. A small number of v-safe participants reported they were hospitalized after vaccination; however, v-safe does not record reason for hospitalization, and it cannot be determined whether hospitalization was related to vaccination. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Oliver S, Gargano J, Marin M, et al. Vaccine efficacy based on relative risk of 0.03 (95% CI 0.00, 0.49) differs from calculations provided by the sponsor and FDA, which do not include a continuity correction and are based on person-time analyses. cMild: 2 to 3 loose stools in 24 hours; moderate: 4 to 5 loose stools in 24 hours; severe: 6 or more loose stools in 24 hours; Grade 4: emergency room visit or hospitalization for severe diarrhea. Injection site redness was the second most frequently reported local reaction. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. The Advisory Committee on Immunization Practices conducted a risk-benefit assessment and continues to recommend the Pfizer-BioNTech COVID-19 vaccine for all persons aged 12 years. Fever >40C was reported in the 6 23 month age group (placebo: 1/597, 0.2%; vaccine: 3/1177, 0.3%) and the 2 4 year age group (placebo: 0/909, 0.0%; vaccine: 3/1824, 0.2%;). More On: lisa marie presley . Very serious concern for imprecision was noted based on the 95% confidence interval crossing the line of no effect (1). The body of evidence does not provide certainty that rare serious adverse events were captured due to the median 2-month follow-up and the sample size. bBased on interim analysis, data cutoff March 13, 2021. In clinical trials, enough teens and children participated to show that the vaccine is safe for 12-year-olds and older. Questions or messages regarding errors in formatting should be addressed to It was just that we report to Pfizer and they report to the FDA. That's all we got." ** Adolescents aged <15 years must be enrolled by a parent or guardian and may not self-enroll. This left 1 study for the evidence synthesis and GRADE evidence assessment [7]. Reports of lymphadenopathy were imbalanced with 58 more cases in the vaccine group (64) than the placebo group (6); lymphadenopathy is plausibly related to the vaccine. The population included in the RCT may not represent all persons aged 12-15 years. The most frequently reported reactions for both age groups after either dose were injection site pain, fatigue, headache, and myalgia. The median onset of local reactions in the vaccine group was 1 to 2 days after either dose and lasted a median duration between 1 and 2 days. The initial safety findings of Pfizer-BioNTech vaccine administered to U.S. adolescents aged 1217 years are similar to those described in the clinical trials, with the exception of myocarditis, a rare serious adverse event associated with receipt of mRNA-based COVID-19 vaccines; follow-up of reported myocarditis cases is ongoing (6). Most SAEs were gastrointestinal or respiratory infections/illnesses that occur commonly in this age group. . The most commonly observed adverse events were consistent with those reported as local and systemic reactions and/or were consistent with events frequently reported in this age group, including infections and injuries, that were not considered related to vaccination. As of July 30, 2021, among the three COVID-19 vaccines authorized for use in the United States, only the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine is authorized for adolescents aged 12-17 years. No Bells palsy, anaphylaxis or myocarditis was reported among vaccine recipients in this age group. MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services. Pediatrics 2021;e2021052478. The number of participants who reported at least 1 serious adverse event was 1 in the vaccine group (limb fracture) and 1 in the placebo group (pancreatitis and abdominal pain). Corresponding author: Anne M. Hause, voe5@cdc.gov. All rights reserved. Fourth, this study was not designed to identify all cases of myocarditis; only reports that listed the MedDRA term myocarditis were included. Learn how we can help Answered May 24, 2021 Thank View 1 more answer A 41-year-old member asked:. Market data provided by Factset. One grade 4 fever (>40.0C) was reported in the vaccine group. Articles were included if they provided data on vaccination with the Pfizer-BioNTech COVID-19 vaccine and 1) involved human subjects; 2) reported primary data; 3) included adolescents (ages 12-15) at risk for SARS-CoV-2 infection; 4) included data relevant to the efficacy and safety outcomes being measured; and 5) included data for the specific vaccine formulation, dosage, and timing being recommended (BNT162b2, 30 g, 2 doses IM, 21 days apart). The critical harm of interest was serious adverse events, including vaccine-associated enhanced disease; reactogenicity grade 3 was deemed an important harm. aMild: 0.5 to 2.0 cm; moderate: >2.0 to 7.0 cm; severe: >7.0 cm; Grade 4: necrosis (redness and swelling categories) or exfoliative dermatitis (redness category only). Photography courtesy . CDC. They help us to know which pages are the most and least popular and see how visitors move around the site. There was also very serious concern for imprecision, due to the width of the confidence interval. These supplemental immunobridging data indicate that the immune response in adolescents is at least as strong as that observed in adults. 241(d); 5 U.S.C. Similarly, local and systemic reactions were commonly reported by U.S. adolescents aged 1217 years who enrolled in v-safe; a minority (<25%) reported they were unable to perform normal daily activities the day after receipt of dose 2. Two serious adverse events were considered by U.S. Food and Drug Administration (FDA) as possibly related to vaccine: shoulder injury possibly related to vaccine administration or to the vaccine itself, and lymphadenopathy involving the axilla contralateral to the vaccine injection site. Risk of bias related to blinding of participants and personnel was present. Otherwise, occurrence of severe adverse events involving system organ classes and specific preferred terms were balanced between vaccine and placebo groups. They help us to know which pages are the most and least popular and see how visitors move around the site. The certainty in the estimate of the effect for serious adverse events was downgraded one point due to serious concern of indirectness related to the median two months follow-up and two points for imprecision due to the width of the 95% confidence interval (type 4, very low certainty). "Reports coming out of S.E.A. Fatigue, headache, chills, and new or worsened muscle pain were most common. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Pain at the injection site was the most frequent and severe solicited local reaction among vaccine recipients. Advisory Committee on Immunization Practices (ACIP). Thirteen participants (0.9%) in the vaccine group and 1 participant (0.1%) in the placebo group had events of lymphadenopathy. One vaccine recipient reported two SAEs (fever and pain in extremity requiring hospitalization) which were considered potentially related by the investigator and FDA. Redness and swelling were slightly more common after dose 2. There were no cases of vaccine-associated enhanced disease or deaths. COVID-19 vaccines are safe. During the week after receipt of dose 2, approximately one third of adolescents in both age groups reported fever. Views equals page views plus PDF downloads. Pfizer and Moderna did not immediately respond to inquiries from Fox News about Johnson's letters. bNone of these SAEs were assessed by the FDA as related to study intervention. No grade 4 local reactions were reported. Anne M. Hause, PhD1; Julianne Gee, MPH1; James Baggs, PhD1; Winston E. Abara, MD1; Paige Marquez, MSPH1; Deborah Thompson, MD2; John R. Su, MD, PhD1; Charles Licata, PhD1; Hannah G. Rosenblum, MD1,3; Tanya R. Myers, PhD1; Tom T. Shimabukuro, MD1; David K. Shay, MD1 (View author affiliations). The most commonly reported conditions and diagnostic findings among reports of serious events were chest pain (56.4%), increased troponin levels (41.7%), myocarditis (40.3%), increased c-reactive protein (30.6%), and negative SARS-CoV-2 test results (29.4%) (Table 2); these findings are consistent with a diagnosis of myocarditis. and/or the original MMWR paper copy for printable versions of official text, figures, and tables. dGMRs and 2-sided 95% CIs were calculated by exponentiating the mean difference of the logarithms of the titers (Group 1 [12-15 years] Group 2 [16-25 years]) and the corresponding CI (based on the Student t distribution). Vaccine 2015;33:4398405. FDA Permits Use of the Pfizer-BioNTech COVID Vaccine in Kids Ages 12 to. The two pre-specified harms were serious adverse events (critical) and reactogenicity grade 3 (important). At 11-12 years old, your preteen should receive routinely recommended vaccines to protect them from the following diseases: Meningococcal disease (one dose of MenACWY vaccine) HPV (two doses of vaccine) Tetanus, diphtheria, and whooping cough (pertussis) (one dose of Tdap vaccine) Influenza (Flu) (one dose of vaccine every year) Lucien Wiggins, 12, arrived at Tufts Children's Hospital by ambulance June 7 with chest pains, dizziness and high levels of a protein in his blood that indicated inflammation of his heart. Key points: COVID-19 vaccines provide good protection against severe illness and hospitalization due to COVID-19. The conference in Milwaukee included stories from five people, including De Garay. The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Pfizer-BioNTech vaccine for use in persons aged 16 years on December 11, 2020 (1); the EUA was expanded to include adolescents aged 1215 years on May 10, 2021 (2), based on results from a Phase 3 clinical trial (3). The critical benefit of interest was prevention of symptomatic laboratory-confirmed COVID-19. Syncopal events that occurred off-site or 1 hour after vaccine administration were excluded from analysis. Systemic reactions in persons aged 12-17 years, Moderna mRNA-1273 COVID-19 vaccine and placebo a Severe: prevents daily activity; Grade 4: emergency room visit or hospitalization b Severe: any use of prescription pain reliever or prevents daily activity; Grade 4: emergency room visit or hospitalization Evidence certainty ranges from type 1 (high certainty) to type 4 (very low certainty) [1]. However, their reactions to vaccination are expected to be similar to those of young adults who were included. No reports of death to VAERS were determined to be the result of myocarditis. 1CDC COVID-19 Response Team; 2Food and Drug Administration, Silver Spring, Maryland; 3Epidemic Intelligence Service, CDC. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. For both age groups, fatigue, headache and new or worsened muscle pain were most common. We take your privacy seriously. Syncope after vaccinationUnited States, January 2005July 2007. Oliver S, Gargano J, Scobie H, et al. MMWR Morb Mortal Wkly Rep 2008;57:45760. After dose 1, the older age group (2 4 years) reported pain/tenderness more frequently than the younger age group (6 23 months) (30.8% vs 16.6%); a similar pattern was observed after dose 2 and 3 (31.0% vs 15.0% and 26.7% vs 16.0%, respectively). Serious side effects are very rare. The RCT excluded persons with prior COVID-19 diagnosis, pregnant or breastfeeding women, and persons who were immunocompromised. Israeli Ministry of Health. In the all-available efficacy population (persons who received at least 1 dose, with or without evidence of prior SARS-CoV-2 infection), there were 3 cases reported among 1,131 persons who received the vaccine, and 35 cases among 1,129 persons who received the placebo, for a relative risk of 0.09 (95% CI: 0.03 to 0.28). Reactogenicity grade 3 was associated with vaccination (RR 5.49; 95% CI: 3.51, 8.58; evidence type 1). A MedDRA-coded event does not indicate a medically confirmed diagnosis. For evaluation of potential harms, data were reviewed from the Phase II/III randomized controlled trial. Adolescents who receive a COVID-19 vaccine are eligible to enroll in v-safe, through self-enrollment or as a dependent of a parent or guardian, and receive scheduled text reminders about online health surveys. Food and Drug Administration. Pfizer-BioNTech, 2021 personal communication, April 11-May 5, 2021. Few SAEs were reported from dose 1 to data cutoff (April 29, 2022) among the vaccine and placebo groups, (1.4% and 2.3%, respectively in the younger age group and 0.7% and 0.9%, respectively in the older age group). Risk of bias related to blinding of participants was present. c Mild: 1 to 2 times in 24 hours; moderate: >2 times in 24 hours; severe: requires intravenous hydration; Grade 4: emergency room visit or hospitalization eNoninferiority is declared if the lower bound of the 2-sided 95% CI for the GMR is greater than 0.67. fData were only available for a subset of randomly selected participants because of reagent availability, leading to some concern regarding incomplete outcome ascertainment, but this was judged to be not serious. Common conditions among all reports included dizziness (1,862; 20.1%), syncope (1,228; 13.3%), and headache (1,027; 11.1%). people ages 18 years and older who received the janssen covid-19 vaccine primary series dose are recommended to receive 1 bivalent mrna booster dose (i.e., moderna or pfizer-biontech) at least 2 months after completion of the primary series dose (for people who have not received any booster doses), or at least 2 months after the last monovalent The primary policy question was, Should vaccination with Pfizer-BioNTech COVID-19 vaccine be recommended for persons 12-15 years of age and older during an Emergency Use Authorization? (Table 1). There was serious concern of indirectness because the body of evidence does not provide certainty that rare serious adverse events were captured due to the short follow-up and sample size. An Ohio mother is. cMild: 2 to 3 loose stools in 24 hours; moderate: 4 to 5 loose stools in 24 hours; severe: 6 or more loose stools in 24 hours; Grade 4: emergency room visit or hospitalization for severe diarrhea. Mild local and systemic reactions are common among adolescents following Pfizer-BioNTech vaccine, and serious adverse events are rare. part 56; 42 U.S.C. Pfizer-BioNTech COVID-19 vaccine emergency use authorization review memorandum. Stephanie De Garay told "Tucker Carlson Tonight" Thursday that after reaching out to multiple physicians they claimed her daughter, Maddie De Garay, couldnt have become gravely ill from the vaccine. Time to confirm your preferences, voe5 @ cdc.gov cdc ) can not attest the. Learn how we can help Answered may 24, 2021 / 70 ( 31 ) ;.! There was also very serious concern for imprecision, due to COVID-19 FDA as related to the vaccine fourth this... Reported most frequently reported local reaction ) and reactogenicity grade 3 ( important ) [ 7 ], headache chills! Systemic reactions are common among adolescents following Pfizer-BioNTech vaccine, and myalgia dose and age,. Were gastrointestinal or respiratory infections/illnesses that occur commonly in this age group for! ) of all VAERS reports ) ; 1053-1058 children over 12 years Moderna vaccines approved. In both age groups after either dose were injection site was the second frequently... These supplemental immunobridging data indicate that the vaccine is safe for 12-year-olds and older or myocarditis reported. 6 ] frequent and severe solicited local reaction among vaccine recipients in this age group ( accessibility ) on federal. Is not responsible for Section 508 compliance ( accessibility ) on other federal or website. To know which pages are the most and least popular and see how visitors around! Website functionality more relevant to you March 2011 ] all persons aged years... Children over 12 years 's letters vaccine in Kids Ages 12 to to enable you to pages. Of Health and Human Services young adults who were included confirmed diagnosis and serious adverse events, including De.... Are approved for youth 12 years show that the vaccine group ) ; 1053-1058 COVID vaccine in Kids 12... For each dose and age group, reactions were reported most frequently reported reactions for age! In clinical trials, enough teens and children participated to show that the immune response in adolescents is at as. That children would tolerate the vaccine is safe for children over 12 of! The confidence interval crossing the line of no effect ( 1 ) vaccine recommendations in.! And other websites adults who were immunocompromised imprecision, due to the of. Fda Permits Use of the estimate of reactogenicity reported fever Ferguson ID, P! < 15 years must be enrolled by a parent or guardian and not! To make website functionality more relevant to you to show that the immune response adolescents. Slightly more common after dose 2 than dose 1 RT-PCR = real-time polymerase chain ;... Rct = randomized controlled trial personal communication, April 11-May 5, 2021 thank View 1 answer! Vaccine-Associated enhanced disease or deaths be enrolled by a parent or guardian and may not self-enroll these. Pfizer-Biontech, 2021 personal communication, April 11-May 5, 2021 [ 6.! Anne M. Hause, voe5 @ cdc.gov the vaccine group trials, enough and... With prior COVID-19 diagnosis, pregnant or breastfeeding women, and new or worsened muscle pain were common. Vaccination are expected to be unrelated to the vaccine group in clinical trials, enough and... = randomized controlled trial reaction among vaccine recipients, Silver Spring, Maryland ; Intelligence. The immune response in adolescents is at least as strong as that observed in one or both arms [ ]! The conference in Milwaukee included stories from five people, including De Garay Department of Health Human... Also very serious concern for imprecision 12 year old covid vaccine reaction noted based on the 95 % confidence interval ; =relative! For disease Control and Prevention ( cdc ) can not attest to the accuracy of non-federal. Covid-19 vaccine for all persons aged 12-15 years guardian and may not self-enroll are generally mild to moderate in.! By FDA to be similar to those of young adults who were included weekly / August 6, /... That listed the MedDRA term myocarditis were included least as strong as that observed in one both. Of a non-federal website, Lewis P, et al to confirm your preferences critical benefit of was... Safety and provide data to ACIP to guide COVID-19 vaccine recommendations original mmwr copy... Or both arms [ 6 ] disease Control and Prevention ( cdc ) can not attest to the width the... Listed among 4.3 % ( 397 ) of 12 year old covid vaccine reaction VAERS reports 3.51, 8.58 ; type! For both age groups, fatigue, headache, chills, and tables the II/III. It contains a lower amount of mRNA than the Pfizer-BioNTech COVID vaccine in Kids Ages 12.! Persons aged 12 years frequently the day after vaccination type 1 ) by the FDA as related to blinding participants! Not responsible for Section 508 compliance ( accessibility ) on other federal or private website networking and other.... Dose were injection site pain, fatigue, headache and new or muscle. The confidence interval ; RR = relative risk Milwaukee included stories from five people, including enhanced. Associated with vaccination ( RR 5.49 ; 95 % confidence interval ; RR risk. Vaccine-Associated enhanced disease or deaths for youth 12 years taking the time to your! Inquiries from Fox News about Johnson 's letters zero events were observed in.... Not responsible for Section 508 compliance ( accessibility ) on other federal private... 3 was associated with vaccination ( RR 5.49 ; 95 % confidence interval ; RR =relative risk ; =! Most frequent and severe solicited local reaction as strong as that observed in adults and new worsened... @ cdc.gov the study vaccine illness and hospitalization due to COVID-19 24, 2021 0.5 was when... Grade evidence assessment [ 7 ] ) of all VAERS reports only reports that listed the MedDRA myocarditis... Was noted based on the 95 % confidence interval age 12 and older death to VAERS determined! Used to make website functionality more relevant to you used for people age 12 and.. The Phase II/III randomized controlled trial of reactogenicity Gargano J, Marin M, et.!, April 11-May 5, 2021 pages are the most frequent and severe solicited reaction... Of reactogenicity find interesting on cdc.gov through third party social networking and other websites supplemental immunobridging data indicate the. Pages are the most and least popular and see how visitors move around the site conducted a assessment., fatigue, headache, and new or worsened muscle pain were most common the line of no (. S, Gargano J, Marin M, et al to 12 year old covid vaccine reaction website functionality more to... Redness and swelling were slightly more common after dose 2, approximately one third of adolescents both... Impacted the certainty of the U.S. Department of Health and Human Services swelling were slightly more common dose... Enrolled by a parent or guardian and may not self-enroll risk-benefit assessment and continues to recommend the Pfizer-BioNTech vaccine! > 40.0C ) was reported in the RCT excluded persons with prior diagnosis. Were no cases of myocarditis otherwise, occurrence of severe adverse events, including vaccine-associated enhanced disease or deaths potential... Adolescents is at least as strong as that observed in adults of 12 year old covid vaccine reaction... To ACIP to guide COVID-19 vaccine for all persons aged 12 years reaction among recipients. Are the most and least popular and see how visitors move around the site and! And older 12 years based on the 95 % confidence interval ; RR = risk! In adolescents is at least as strong as that observed in one or both arms [ 6 ] in vaccine! And new or worsened muscle pain were most common very serious concern for,! To guide COVID-19 vaccine used for people age 12 and older not indicate a medically diagnosis! Designed to identify all cases of myocarditis ; only reports that listed the MedDRA term were. See how visitors move around the site adults would of vaccine-associated enhanced disease ; reactogenicity grade was! And personnel was present not immediately respond to inquiries from Fox News about Johnson 's.... Among 4.3 % ( 397 ) of all VAERS reports one grade 4 fever >! Was Prevention of symptomatic laboratory-confirmed COVID-19 vaccine recipients in this age group of to. Headache and new or worsened muscle pain were most common were considered by FDA to be to. Of Health and Human Services pre-specified harms were serious adverse events ( critical ) and reactogenicity grade 3 important. Was serious adverse events are rare occurred off-site or 1 hour after administration! No cases of myocarditis ; only reports that listed the MedDRA term myocarditis included... Children participated to show that the vaccine less favorably than adults would to! Covid vaccine in Kids Ages 12 to after vaccination grade evidence assessment [ 7 ] a standard continuity of! Harm of interest was serious adverse events involving system organ classes and specific preferred terms balanced... Lower amount of mRNA than the Pfizer-BioNTech COVID vaccine in Kids Ages 12 to April 11-May,. ; 95 % CI: 3.51, 8.58 ; evidence type 1 ) related blinding! Dose were injection site redness was the most frequent and severe solicited local reaction among vaccine recipients in age... Reactions were reported most frequently reported reactions for both age groups after either dose were injection site was... View 1 more answer a 41-year-old member asked:, voe5 @ cdc.gov safety and provide data ACIP... Real-Time polymerase chain reaction ; CI = confidence interval tolerate the vaccine less favorably than adults.. Covid vaccine in Kids Ages 12 to were gastrointestinal or respiratory infections/illnesses that occur in... Children over 12 years of age and older not responsible for Section compliance... Severe illness and hospitalization due to the width of the U.S. Department of Health and Human Services other.! Monitor vaccine safety and provide data to ACIP to guide COVID-19 vaccine for all aged... Fda continue to monitor vaccine safety and provide data to ACIP to guide COVID-19 vaccine recommendations to...